Meaning
Risk management standards designed for medical device manufacturing define systematic frameworks for identifying hazards, estimating risks and controlling component failures across product lifecycles. Material selection processes adhere to iso 14971 to systematically evaluate biocompatibility risks, polymer degradation products and manufacturing defects. Tooling engineers use risk matrices to determine critical process controls during injection moulding setup.
Scope of application extends from initial material qualification through post production market surveillance.
Hazard Analysis
Systematic risk evaluations identify failure modes stemming from material selection, tooling design and processing drift. Compliance with iso 14971 requires moulders to map bio-reactivity hazards from leachable plasticizers and heavy metal catalysts. Failure mode and effects analysis isolates high risk manufacturing steps.
Risk Mitigation
Engineering controls reduce identified risks by modifying mold geometry or tightening barrel temperature parameters. Process validation protocols written under iso 14971 mandate complete traceability of virgin resin lots and regrind ratios. Part redesign eliminates thin walls prone to short shots during high speed moulding.
Physical testing confirms hazard mitigation.
Compliance Boundary
Residual risk assessments confirm that all identified hazards fall within acceptable safety thresholds prior to commercial distribution. Documentation files compile physical test data, bio-compatibility reports and capability studies. Audits verify ongoing adherence to documented risk management plans.
Full adherence to iso 14971 satisfies regulatory submission requirements.